BN trades 32.2% below Wall Street's consensus target of $58.75.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BN achieves its forward estimates and maintains a stable P/E multiple of 16.1x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Brookfield Corporation (BN) has a Wall Street consensus price target of $58.75, based on estimates from 9 covering analysts. With the stock currently trading at $44.44, this represents a potential upside of +32.2%. The company has a market capitalization of $99.42B.
Analyst price targets range from a low of $53.00 to a high of $61.00, representing a 14% spread in expectations. The median target of $60.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BN trades at a trailing P/E of 88.9x and forward P/E of 16.1x. Analysts expect EPS to grow +388.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $49.65, with bear and bull scenarios of $31.28 and $65.42 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
BXBlackstone Inc. | $97.0B | $123.78 | $156.29 | +26.3% | Buy | 21.0x | 29 |
KKRKKR & Co. Inc. | $86.5B | $97.01 | $141.14 | +45.5% | Buy | 16.1x | 27 |
APOApollo Global Management, Inc. | $79.3B | $137.50 | $153.50 | +11.6% | Buy | 15.4x | 28 |
CGThe Carlyle Group Inc. | $16.2B | $44.80 | $61.00 | +36.2% | Buy | 11.1x | 25 |
ARESAres Management Corporation | $42.5B | $129.34 | $171.13 | +32.3% | Buy | 21.5x | 22 |
BAMBrookfield Asset Management Ltd. | $77.7B | $47.44 | $58.44 | +23.2% | Buy | 26.4x | 20 |
BEPBrookfield Renewable Partners L.P. | $10.8B | $35.24 | $36.67 | +4.1% | Buy | — | 20 |
BIPBrookfield Infrastructure Partners L.P. | $17.4B | $37.57 | $46.00 | +22.4% | Buy | 30.4x | 17 |
BIPCBrookfield Infrastructure Corporation | $4.8B | $39.61 | $57.00 | +43.9% | Buy | 304.7x | 2 |
BEPCBrookfield Renewable Corporation | $5.4B | $37.42 | $36.00 | -3.8% | Buy | — | 4 |
Quick answers to the most common questions about buying BN stock.
The consensus Wall Street price target for BN is $58.75, representing 32.2% upside from the current price of $44.44. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BN has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $58.75 implies 32.2% upside from current levels.
With a forward P/E of 16.1412x, BN trades at a relatively low valuation. The consensus target of $58.75 implies 32.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $61 for BN, while the most conservative target is $53. The consensus of $58.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $65 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BN stock forecast based on 9 Wall Street analysts shows a consensus price target of $58.75, with estimates ranging from $53 (bear case) to $61 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $50, with bear/bull scenarios of $31/$65.
Our quantitative valuation model calculates BN's fair value at $50 (base case), with a bear case of $31 and bull case of $65. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
BN trades at a forward P/E ratio of 16.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 88.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on BN, with a "Buy" consensus rating and $58.75 price target (32.2% upside). 8 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BN analyst price targets range from $53 to $61, a 14% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $58.75 consensus represents the middle ground. Our model's $31-$65 range provides an independent fundamental perspective.
Deep dive into BN consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.